Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Stanford Cardiovascular Institute are organizing weekly virtual CVI Frontiers in Cardiovascular Science Seminar. The Zoom webinars are open to the public. We encourage you to attend and have a lively Q&A discussion. Below are the Zoom details for our upcoming speaker. Speaker: Joan Heller Brown, PhD, Distinguished Professor and Chair, Department of Pharmacology, UCSD School […]
For this month's webinar, Quinn Bonafiglia will presenting on the talk "Pulmonary Hypertension in Discoidin Domain Receptor 1 Deficient Mice". He is a student in Michelle Bendeck's lab at University of Toronto. Professor Bendeck is known for her pioneering work in vascular matrix biology. Her research on cellmatrix interactions in atherosclerosis and its complications is […]
Building a Successful Start-Up in the Midst of a Pandemic Dr. Naimark is one of the founders of Ripple Therapeutics (RIPL) following its spin out from Interface Biologics (IBI) in 2020. Dr. Naimark has been leading teams in the development of local drug delivery products for over 20 years. She joined IBI in 2016 and […]
The Ted Rogers Centre for Heart Research (TRCHR) initiated monthly lab meetings in May 2018. They take place on the last Tuesday of the month, from 4 -5 pm. This month, the lab meeting will take place on Tuesday, Jan 26, 2021, from 4-5 pm on Zoom. Please see the table below for more info […]